Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System
- PMID: 29436251
- PMCID: PMC6134610
- DOI: 10.1177/1932296818758104
Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System
Abstract
Background: Self-monitoring of blood glucose (SMBG) using the ColourSure™ Technology to visualize target range showed improvement of metabolic control and overall diabetes self-management in insulin-treated patients. This economic analysis aimed to identify cost savings for the German health system resulting from an HbA1c reduction due to the utilization of user-friendly glucose meters.
Methods: Patient data from a recently published observational study on SMBG were used for risk evaluations using the UKPDS risk engine. These values were integrated in an economic analysis regarding costs of myocardial infarctions (MIs) related to diabetes for the German health system. Based on an earlier assessment these calculations were combined with a 10% reduction of severe hypoglycemic episodes. In the current study, 0% severe hypoglycemic episodes were observed.
Results: An HbA1c reduction of 0.69% over 6 months was associated with a 3% decreased risk of MI in 10 years. In this model the decrease led to cost savings of €4.90 per patient-year. Considering 2.3 million insulin-treated patients in Germany, this 3% reduction of MI could result in annual savings of €11.27 million. Combining this with a 10% reduction in severe hypoglycemic events, the cost savings would increase to €30.61 per patient-year or €70.4 million for 2.3 million insulin-treated patients in Germany.
Conclusion: The improvement of metabolic control and diabetes self-management that was achieved with the ColourSure™ Technology has the potential to generate substantial cost savings for the German health system underlining the importance of user-friendly methods for SMBG.
Keywords: ColourSure™ Technology; Diabetes; Economic Analysis; Self-Monitoring of Blood Glucose.
Conflict of interest statement
Similar articles
-
Impact of a reduced error range of SMBG in insulin-treated patients in Germany.J Diabetes Sci Technol. 2014 May;8(3):479-82. doi: 10.1177/1932296813516206. Epub 2014 Feb 5. J Diabetes Sci Technol. 2014. PMID: 24876609 Free PMC article.
-
Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.J Diabetes Sci Technol. 2013 Jul 1;7(4):904-12. doi: 10.1177/193229681300700413. J Diabetes Sci Technol. 2013. PMID: 23911172 Free PMC article.
-
Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid.J Manag Care Spec Pharm. 2024 Sep;30(9):917-928. doi: 10.18553/jmcp.2024.24025. Epub 2024 Aug 7. J Manag Care Spec Pharm. 2024. PMID: 39109990 Free PMC article.
-
Importance of using and understanding self-monitoring of blood glucose (SMBG) data in assessing ambient and long-term glycaemic control.J Indian Med Assoc. 2002 Jul;100(7):448, 450-1. J Indian Med Assoc. 2002. PMID: 12674169 Review.
-
Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.J Eval Clin Pract. 2018 Aug;24(4):772-781. doi: 10.1111/jep.12987. Epub 2018 Jul 3. J Eval Clin Pract. 2018. PMID: 29971893 Review.
Cited by
-
Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.J Diabetes Sci Technol. 2020 Mar;14(2):262-270. doi: 10.1177/1932296819864665. Epub 2019 Aug 6. J Diabetes Sci Technol. 2020. PMID: 31387385 Free PMC article.
-
Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management.J Diabetes Sci Technol. 2019 Nov;13(6):1112-1122. doi: 10.1177/1932296819835172. Epub 2019 Mar 27. J Diabetes Sci Technol. 2019. PMID: 30917691 Free PMC article.
-
Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.BMC Health Serv Res. 2020 Nov 16;20(1):1043. doi: 10.1186/s12913-020-05897-w. BMC Health Serv Res. 2020. PMID: 33198734 Free PMC article.
References
-
- Kesavadev J, Ramachandran L, Krishnan G. Better outcomes in type 2 diabetes management with a user friendly flash glucose monitoring system: Freestyle Libre Pro. Presentation at: 10th International Conference on Advanced Technologies & Treatments for Diabetes; February 15-18, 2017; Paris, France.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical